Clinical Trial Update: Phase I Study of TBI-1401(HF10) Plus Chemotherapy in Patients with Unresectable Pancreatic Cancer. [Phase 1]

View source ↗

Summary

A Phase I trial evaluating TBI-1401 (HF10) in combination with chemotherapy for unresectable pancreatic cancer (Stage III/IV) is listed, with the study currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• TBI-1401(HF10) (HF10 oncolytic herpes simplex virus type 1)

Snippet

Sponsor: Takara Bio Inc. | Conditions: Pancreatic Cancer Stage III, Pancreatic Cancer Stage IV | Phase 1 | Status: ACTIVE_NOT_RECRUITING